Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23651,189,2.32 [1.51-3.57],0.0001366285069782
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23402,1407,1.90 [1.61-2.24],1.8131515626811242e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Candidiasis,23664,379,3.14 [2.35-4.19],7.506256654171162e-15
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22976,3469,1.84 [1.65-2.04],1.4208340662448456e-29
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22930,3485,1.87 [1.68-2.07],1.522042178797645e-31
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23450,1036,1.81 [1.49-2.19],1.3191185805203435e-09
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23585,79,2.93 [1.54-5.55],0.0010104932607314
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21448,1120,2.37 [1.98-2.83],3.553665799360647e-21
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20693,1241,2.42 [2.04-2.87],4.508331309611749e-24
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20411,251,4.09 [2.90-5.75],6.829274045459374e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16645,2266,2.02 [1.77-2.30],1.049400208874583e-25
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20342,404,2.32 [1.71-3.14],5.186689011119632e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23654,1240,1.89 [1.59-2.25],5.751258913960757e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,23753,468,2.74 [2.10-3.57],1.1053718772348508e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22888,893,2.16 [1.76-2.64],1.0961471674620665e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23678,1236,2.23 [1.88-2.64],4.15730680809297e-20
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22605,191,2.38 [1.55-3.67],8.054270606039963e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23521,1079,2.26 [1.89-2.72],1.983523184744203e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23731,122,3.00 [1.78-5.05],3.642396667186069e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23711,102,2.91 [1.64-5.18],0.000263483934007
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22485,490,2.19 [1.67-2.88],1.8161455477644065e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22281,286,1.87 [1.29-2.70],0.0008901476881036
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22502,88,3.11 [1.69-5.73],0.0002629570241885
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23773,67,2.68 [1.33-5.40],0.0056823129238954
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23416,1638,1.35 [1.15-1.58],0.0002025152243748
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23747,562,1.48 [1.13-1.92],0.003913106351074
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18477,72,2.60 [1.29-5.24],0.0076351742817743
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lung cancer and mesothelioma,15835,341,2.55 [1.84-3.54],1.9679852509883967e-08
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18498,93,5.04 [2.97-8.57],2.1409213585016086e-09
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18543,138,2.22 [1.35-3.66],0.0017554672107138
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18623,218,1.73 [1.16-2.56],0.0068213995244136
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19608,1203,1.38 [1.15-1.67],0.0006654231242552
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19686,1281,1.39 [1.16-1.67],0.0003406945709403
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23519,307,2.21 [1.57-3.11],5.986877616221474e-06
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22060,119,2.83 [1.64-4.88],0.0001907180500084
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23282,70,2.81 [1.40-5.67],0.003848589320402
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23234,2786,1.96 [1.74-2.20],2.9064027496527415e-29
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22513,63,6.09 [3.29-11.25],8.225968538051007e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23414,1473,1.98 [1.69-2.32],5.704075666855828e-17
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23412,1471,1.97 [1.68-2.32],8.866859086253386e-17
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22043,102,3.28 [1.83-5.87],6.233028330510119e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23550,1100,2.09 [1.74-2.51],2.379578433043929e-15
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23287,75,3.93 [2.12-7.28],1.3902016211115144e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23630,314,2.51 [1.80-3.49],5.390070986318312e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23573,257,2.96 [2.07-4.23],2.447090344808142e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22528,78,5.46 [3.07-9.69],6.810516651775436e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17525,376,2.20 [1.60-3.02],1.1228605707469609e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21761,163,4.80 [3.19-7.21],4.5211737662243524e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21788,190,9.98 [7.18-13.88],1.3587002910738785e-42
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17206,57,3.45 [1.60-7.46],0.0016200788406441
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21654,223,2.07 [1.39-3.09],0.0003600497262298
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23289,617,1.77 [1.38-2.26],6.800518637021777e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23495,1139,1.73 [1.44-2.07],2.9279810774700622e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20363,1096,2.01 [1.66-2.42],3.372974601220412e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17423,274,2.47 [1.71-3.56],1.326324608205514e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17225,76,4.21 [2.19-8.09],1.6964518109668963e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21036,3887,1.21 [1.09-1.34],0.0002550754077185
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17337,188,3.94 [2.59-6.00],1.5547225782073492e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17722,573,2.80 [2.18-3.59],5.2084089375009815e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17303,154,2.86 [1.77-4.63],1.9166777718894004e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17215,66,3.69 [1.79-7.62],0.0004068086482013
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23618,743,1.80 [1.43-2.25],4.038063771447229e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17457,308,2.62 [1.85-3.69],4.347197753918922e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17530,381,3.52 [2.60-4.75],2.961609947879105e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17877,728,1.51 [1.19-1.91],0.0006279215000266
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17720,571,2.62 [2.03-3.38],1.5071749511142446e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17540,391,2.90 [2.14-3.93],6.769716323302408e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22353,5204,1.41 [1.29-1.54],1.8418221370985605e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22898,23,4.54 [1.56-13.21],0.0055819895280797
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23524,797,1.63 [1.31-2.03],1.340514777259984e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18772,1623,2.30 [1.98-2.68],3.4895540064196046e-27
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23781,266,3.37 [2.41-4.72],1.5655582747180088e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21015,169,4.18 [2.72-6.43],7.318024726208859e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2497,124,2.20 [1.32-3.68],0.0025717033801359
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20948,102,5.72 [3.37-9.70],9.883320482531192e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23005,2159,2.55 [2.25-2.90],4.625202523165922e-47
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21671,240,2.98 [2.08-4.26],2.502124489644448e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17947,798,2.50 [2.02-3.09],4.563596438750535e-17
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22564,277,1.70 [1.17-2.46],0.0050497258757946
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,20871,1492,1.33 [1.13-1.57],0.000591652504359
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22672,385,1.63 [1.19-2.24],0.0023862596068696
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22369,82,3.50 [1.90-6.44],5.711940008667268e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22537,250,3.51 [2.47-5.00],3.029391746697888e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13924,2311,1.58 [1.38-1.81],2.6261782962766804e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiac arrest,11862,249,2.38 [1.58-3.58],3.09784018803436e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,19876,1362,1.34 [1.13-1.60],0.0007475299314368
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21979,2624,1.44 [1.28-1.63],4.578395875681273e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20036,7756,1.42 [1.32-1.52],7.599893931907216e-21
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Endocarditis,18596,82,2.58 [1.33-5.00],0.004934207889355
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23484,1330,1.65 [1.39-1.95],1.1009534737084373e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,21239,6764,1.45 [1.34-1.57],7.58363494351756e-21
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21261,6786,1.44 [1.33-1.55],4.600815678269757e-20
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23560,110,18.32 [12.60-26.62],1.87747461245988e-52
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14656,181,3.22 [2.07-5.00],2.117227174635752e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14645,170,2.20 [1.37-3.53],0.0010515258373974
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,23645,1242,2.09 [1.76-2.48],3.606617893346007e-17
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22121,2742,1.35 [1.20-1.52],1.1023025706009432e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23365,653,1.78 [1.40-2.27],2.2602900714887125e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20300,921,1.33 [1.08-1.63],0.0075851459734583
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Oesophageal varices,22355,69,23.35 [15.04-36.24],8.420355430071238e-45
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22421,134,2.88 [1.76-4.72],2.5314208288182416e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22570,283,2.10 [1.48-2.98],3.630920754319083e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19767,1253,1.44 [1.21-1.72],5.964529034752909e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22469,66,18.31 [11.36-29.52],7.556449195051435e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22865,578,2.01 [1.57-2.57],2.997293189991136e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23146,361,2.73 [2.02-3.69],7.526700161966104e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22778,668,1.66 [1.30-2.11],3.901210428105506e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11992,379,2.10 [1.50-2.92],1.2994431548093945e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22775,535,2.41 [1.87-3.09],5.930648084159448e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23732,718,1.37 [1.08-1.73],0.009029474189692
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23144,359,2.67 [1.97-3.62],2.3799792634438637e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22335,225,2.55 [1.73-3.76],2.4620887416032423e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23349,743,1.71 [1.36-2.14],3.262493903278952e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23333,773,1.69 [1.36-2.11],3.238244599230755e-06
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23596,496,5.35 [4.25-6.74],4.321635672149635e-46
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20458,966,1.85 [1.51-2.27],2.0768780523491782e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,23116,3624,1.70 [1.53-1.88],4.3008723560153936e-24
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23534,584,4.43 [3.55-5.53],1.9621023066985043e-39
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20667,1175,1.96 [1.64-2.35],3.136340734490553e-13
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,23152,1527,2.03 [1.75-2.34],1.850205041101141e-21
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21352,1860,2.26 [1.98-2.58],6.2969809317896495e-34
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Vascular dementia,23281,148,2.04 [1.24-3.35],0.0049927326269123
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral cysts,23386,241,2.29 [1.56-3.38],2.5255549640349176e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23706,366,1.66 [1.21-2.29],0.0018542516620739
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23256,1362,1.32 [1.11-1.57],0.0014280867731898
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23247,2220,1.74 [1.53-1.99],1.513279598974732e-16
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,23623,283,1.77 [1.23-2.53],0.001972007721099
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,22475,3667,1.28 [1.15-1.42],4.314642824587735e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23465,243,1.82 [1.23-2.68],0.0027178134922319
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23701,352,2.74 [2.01-3.74],2.0896668745016677e-10
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18657,622,1.43 [1.11-1.86],0.0062570340476613
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,23673,528,1.87 [1.44-2.45],3.806375935414167e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23251,144,1.97 [1.19-3.27],0.0084585126816347
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23591,291,2.74 [1.95-3.86],6.9919476399485525e-09
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2994,131,1.91 [1.17-3.12],0.0094431866734046
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22416,1790,1.27 [1.09-1.47],0.0022070788918471
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23776,148,1.96 [1.19-3.24],0.0083891112921368
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22104,1478,1.32 [1.12-1.56],0.0011013483443159
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23545,387,1.61 [1.18-2.21],0.00288873585436
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23327,169,1.86 [1.17-2.96],0.0090172589674633
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23698,960,1.43 [1.16-1.75],0.0006824795062387
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23446,708,1.54 [1.21-1.95],0.0003662197205613
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16569,1422,1.48 [1.25-1.76],7.892996523051184e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16892,1398,1.48 [1.24-1.76],1.2082383272121713e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bronchiectasis,20698,291,1.73 [1.20-2.50],0.0036240275640757
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20451,44,4.33 [1.90-9.89],0.0005013771126611
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22948,2541,1.57 [1.38-1.77],1.345054976085176e-12
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23571,1295,2.08 [1.76-2.46],5.327087340071661e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21790,5275,1.57 [1.44-1.71],9.100669434528325e-24
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,22576,300,2.88 [2.11-3.94],2.622845456197748e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Emphysema,20755,348,2.60 [1.90-3.55],2.105138359267933e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22867,335,2.25 [1.62-3.12],1.1814578261056684e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23548,2147,1.89 [1.66-2.16],5.119767859217994e-21
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,22896,364,2.27 [1.66-3.11],2.7875705483731134e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Later onset COPD,22733,995,1.86 [1.53-2.26],5.31588533788865e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23775,421,1.84 [1.37-2.48],5.605304293960507e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23521,1003,1.69 [1.39-2.06],1.204821024642095e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,23516,2204,1.90 [1.67-2.16],4.346384628642143e-22
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other pleural conditions,21378,66,6.51 [3.54-11.99],1.797605813120095e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23701,446,2.19 [1.65-2.91],4.9656008500925856e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23670,1397,1.73 [1.47-2.04],4.6216583894815095e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,22434,1122,2.24 [1.88-2.68],5.024111374133822e-19
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural plaque,21579,267,2.39 [1.65-3.47],4.269143166612321e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23284,1883,1.86 [1.61-2.14],9.65633345902496e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23678,324,1.80 [1.28-2.53],0.0007488346242365
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pulmonary oedema,23322,67,3.55 [1.82-6.92],0.0001982678208357
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23503,985,1.74 [1.43-2.12],2.7472368071907616e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Viral pneumonia,21683,282,1.68 [1.16-2.45],0.006584894722992
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23430,239,1.85 [1.24-2.76],0.0026222749486967
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10368,115,2.21 [1.24-3.97],0.0075235274865055
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16614,90,2.40 [1.29-4.49],0.0059121217365402
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute gastritis,17961,90,2.97 [1.57-5.63],0.0008086400550423
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,22438,202,3.04 [2.02-4.57],1.012178948930793e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute peritonitis,23427,98,5.05 [2.98-8.56],1.901296086992298e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22905,117,21.18 [14.87-30.18],4.5209756479973245e-64
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Barrett oesophagus,18395,524,2.28 [1.74-2.99],2.302145459614855e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22357,121,2.15 [1.24-3.72],0.0062539087624253
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23385,121,2.08 [1.20-3.60],0.0092081545990088
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,23023,787,2.05 [1.65-2.55],8.591205677029057e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,18136,265,2.16 [1.48-3.17],7.442060356871941e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22293,57,4.63 [2.32-9.24],1.3364600686851786e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23583,133,17.99 [12.76-25.36],3.648719755192003e-61
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,22161,92,8.35 [5.13-13.57],1.1453790585802224e-17
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,23629,1590,1.47 [1.26-1.72],1.6066155552092186e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,23150,226,1.92 [1.30-2.86],0.0011581955800987
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20154,1950,1.53 [1.32-1.76],7.04839245974469e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,23654,866,4.31 [3.57-5.19],5.650392385565012e-53
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21811,3940,1.66 [1.50-1.84],5.49000373772788e-23
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23431,507,1.86 [1.42-2.43],5.795701386106977e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23742,413,2.23 [1.66-3.00],1.1216223186481689e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23477,1408,1.88 [1.60-2.21],3.021927018011728e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of tongue,22911,109,2.33 [1.31-4.13],0.0038934221493015
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23422,1186,2.23 [1.87-2.65],1.4615720668265455e-19
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19573,3049,1.34 [1.19-1.51],7.258395355614041e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,18139,268,2.55 [1.77-3.69],6.147897605145685e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23679,210,2.39 [1.60-3.57],2.013765201589376e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23718,47,3.08 [1.34-7.08],0.0079313796139252
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22944,156,14.91 [10.67-20.83],2.2567966977120777e-56
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,18235,364,2.37 [1.72-3.26],1.1408514065835605e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20022,2151,1.60 [1.39-1.83],2.9966118705829813e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18466,595,2.24 [1.74-2.88],2.9529975110747767e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18185,7980,1.35 [1.26-1.45],4.0171424041084813e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,23241,1172,1.72 [1.43-2.06],4.242400865590936e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22875,87,8.98 [5.34-15.08],1.1223232549196246e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,21743,3539,1.25 [1.12-1.39],7.025529003831797e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22174,105,7.35 [4.59-11.78],1.1353384278833792e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23752,377,3.91 [2.93-5.20],9.910774013677296e-21
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22980,680,1.96 [1.55-2.47],1.7228119118176573e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23190,890,1.78 [1.45-2.19],3.932597746460416e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18083,212,2.58 [1.70-3.91],7.456706630394933e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,18500,629,2.45 [1.92-3.12],3.783472114067287e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17957,1433,1.49 [1.26-1.77],3.0702047828181293e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22493,257,1.91 [1.30-2.81],0.0009152737969012
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22354,118,2.10 [1.20-3.68],0.0096724556573542
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,18400,1876,1.54 [1.33-1.78],6.905100767380251e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,21980,5456,1.38 [1.26-1.50],3.5043853332741693e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,23478,690,3.94 [3.18-4.87],2.0238040056443384e-36
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18605,734,2.22 [1.76-2.78],9.020019199445047e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22377,141,3.27 [2.04-5.24],7.826169820128339e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23671,342,1.82 [1.31-2.54],0.0004174322503676
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18675,804,3.19 [2.58-3.94],3.461798635583131e-27
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23251,1182,1.70 [1.42-2.04],7.107498228059931e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18151,1627,1.58 [1.35-1.85],8.9521024878235e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19747,1876,2.02 [1.75-2.33],9.130425790552516e-22
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22884,96,7.71 [4.63-12.84],4.518301447218083e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23079,779,1.93 [1.55-2.41],3.3981836286613796e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16875,351,1.68 [1.20-2.34],0.0024324761697247
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23710,56,3.09 [1.44-6.61],0.0036356289969781
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17001,477,1.65 [1.24-2.20],0.0006528995214975
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22235,166,2.18 [1.36-3.48],0.0011187707175883
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22933,106,2.69 [1.52-4.74],0.0006583503700484
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18170,299,2.16 [1.51-3.08],2.366500226811297e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16682,158,2.27 [1.40-3.69],0.0009546769387585
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,18463,259,1.79 [1.21-2.62],0.0031647986799502
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23473,66,4.81 [2.49-9.31],3.03521117338566e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23057,764,1.50 [1.20-1.88],0.0003909358575291
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22168,467,1.79 [1.36-2.37],4.387231649662157e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23499,266,1.82 [1.25-2.66],0.0017779255964938
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23703,470,1.78 [1.34-2.37],6.170523186124722e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22307,3178,1.30 [1.17-1.46],3.5967011671609006e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23332,1039,1.43 [1.18-1.74],0.0002733486179375
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21724,23,5.41 [1.84-15.90],0.0021432945818566
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23495,262,1.81 [1.24-2.65],0.0022306957645964
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23336,1635,1.32 [1.13-1.54],0.000535965686987
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23703,296,1.75 [1.22-2.50],0.0022608838717675
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23667,260,1.85 [1.27-2.70],0.0014920217600464
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21974,273,2.25 [1.58-3.21],7.758780225840266e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20539,91,2.83 [1.54-5.22],0.0008633862656706
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21706,4770,1.19 [1.08-1.31],0.0002651469137075
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20892,152,2.01 [1.23-3.29],0.0054642598868206
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20247,6253,1.22 [1.12-1.32],2.0334739273467224e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22970,2230,1.35 [1.18-1.55],1.1143026836484732e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20812,364,1.63 [1.17-2.27],0.0038027729501089
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17921,985,1.43 [1.17-1.75],0.0005722938372446
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23651,971,1.40 [1.14-1.71],0.0011835832278764
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22737,92,4.06 [2.30-7.18],1.3748026638938035e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23504,859,1.81 [1.47-2.23],2.193128118668699e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23045,400,1.94 [1.44-2.62],1.544759720266891e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18815,1879,1.24 [1.06-1.44],0.0053612448143141
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22265,1525,1.41 [1.20-1.66],2.736800490728748e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21351,611,1.59 [1.23-2.05],0.0003745158863559
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23774,60,5.59 [2.86-10.93],5.06758898472001e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21438,990,1.34 [1.10-1.64],0.0044385537036979
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21221,481,1.53 [1.15-2.04],0.0036063010210159
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19504,576,1.85 [1.42-2.40],4.259729321931689e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20777,329,1.60 [1.13-2.27],0.0079638241661029
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19198,2262,1.35 [1.18-1.55],1.145582003465632e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16998,62,5.51 [2.79-10.88],9.010250188395664e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17233,297,1.64 [1.14-2.36],0.0080836958960919
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22722,2274,1.24 [1.08-1.41],0.0019881307750394
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22056,1316,1.41 [1.18-1.68],0.0001233940030719
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21564,824,1.36 [1.09-1.70],0.0057485110614382
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,40,5.25 [2.34-11.81],5.884737866578641e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22784,1867,2.03 [1.77-2.34],3.499761215674037e-23
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22468,1551,1.50 [1.27-1.75],7.812462982889689e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21415,5586,1.28 [1.17-1.39],2.3063147342783083e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23559,103,3.40 [1.95-5.92],1.6127204137919666e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22964,2258,1.30 [1.14-1.49],0.0001131839306043
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22243,1537,1.54 [1.31-1.80],1.6651107114890457e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23490,2836,1.65 [1.47-1.86],3.136992440469392e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21075,158,3.06 [1.95-4.83],1.3189116699459334e-06
